JUN and neoplasm: Overall, our findings indicate that MAGEA2 plays a crucial role in tumor-stromal crosstalk, which controls chemoresistance and metastasis by regulating both the GFRAL-RET mediated Akt and ERK1/2 dependent survival pathway, and the JNK-c-Jun-p53 mediated apoptosis pathway.